Evolent Health, Inc

Historical 13F Holders

Symbol
EVH
CUSIP
30050B101
All holders as of
Q3 2026
Type
Equity
Class
CL A
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 30050B101 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock Portfolio Management LLC 13G 5.5% 7/17/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (9)
Boehler Adam 13G/A
4.99% 11/13/2026
Event 9/9/2026
RA Capital Management, L.P. 13G/A
3.1% 2/14/2025
Event 12/31/2024
Morgan Stanley 13G/A
2.7% 9/8/2026
Event 8/31/2026
FMR LLC 13G/A
0.7% 2/5/2026
Event 12/31/2025
Cadian Capital Management, LP 13G/A
0.5% 11/16/2026
Event 9/30/2026
Wellington Management Group LLP 13G/A
0.4% 7/7/2025
Event 6/30/2025
Eventide Asset Management, LLC 13G/A
0% 2/13/2026
Event 12/31/2025
Durable Capital Partners LP 13G/A 0% 11/14/2025
Event 9/30/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 195 105 M $372M
2026 Q2 200 112 M $608M
2026 Q1 195 111 M $253M
2025 Q4 221 121 M $482M
2025 Q3 243 137 M $1.16B
2025 Q2 225 132 M $1.48B
2025 Q1 234 126 M $1.20B
2024 Q4 247 122 M $1.37B
2024 Q3 274 130 M $3.65B
2024 Q2 245 130 M $2.47B
2024 Q1 255 126 M $4.13B
2023 Q4 237 126 M $4.18B
2023 Q3 208 122 M $3.34B
2023 Q2 218 118 M $3.55B
2023 Q1 242 112 M $3.62B
2022 Q4 233 101 M $2.83B
2022 Q3 255 95.3 M $3.42B
2022 Q2 217 89.7 M $2.76B
2022 Q1 220 86.5 M $2.79B
2021 Q4 213 84.7 M $2.34B
2021 Q3 214 85.6 M $2.65B
2021 Q2 181 83.0 M $1.75B
2021 Q1 172 82.0 M $1.66B
2020 Q4 165 81.5 M $1.31B
2020 Q3 161 80.0 M $997M
2020 Q2 141 73.5 M $522M
2020 Q1 160 78.6 M $434M
2019 Q4 174 84.4 M $764M
2019 Q3 182 83.9 M $603M
2019 Q2 188 79.7 M $633M
2019 Q1 196 80.1 M $1.01B
2018 Q4 191 84.5 M $1.69B
2018 Q3 191 83.7 M $2.38B
2018 Q2 178 81.5 M $1.72B
2018 Q1 153 79.3 M $1.13B
2017 Q4 158 77.3 M $951M
2017 Q3 167 73.8 M $1.32B
2017 Q2 170 62.0 M $1.57B
2017 Q1 134 41.6 M $921M
2016 Q4 121 29.4 M $435M
2016 Q3 111 27.3 M $679M
2016 Q2 80 18.0 M $345M
2016 Q1 70 16.5 M $174M
2015 Q4 69 16.1 M $195M
2015 Q3 69 15.8 M $252M
2015 Q2 63 14.8 M $288M